Recent News

• 02.28.2025 - B. Riley Securities Precision Oncology & Radiopharma Conference 2025
• 02.28.2025 - B. Riley Securities Precision Oncology & Radiopharma Conference 2025
• 02.20.2025 - Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
• 02.20.2025 - Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
• 02.05.2025 - Guggenheim Securities SMID Cap Biotech Conference
• 02.05.2025 - Guggenheim Securities SMID Cap Biotech Conference
• 01.29.2025 - Verastem Oncology to Present at the Guggenheim SMID Cap Biotech Conference
• 01.29.2025 - Verastem Oncology to Present at the Guggenheim SMID Cap Biotech Conference
• 01.23.2025 - Verastem Oncology Outlines 2025 Strategic Priorities and Milestones for Novel Pipeline Targeting RAS/MAPK Pathway-Driven Cancers
• 01.23.2025 - Verastem Oncology Outlines 2025 Strategic Priorities and Milestones for Novel Pipeline Targeting RAS/MAPK Pathway-Driven Cancers

Recent Filings

• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.11.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.31.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors